BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30238562)

  • 1. Long non-coding RNA MIF-AS1 promotes gastric cancer cell proliferation and reduces apoptosis to upregulate NDUFA4.
    Li L; Li Y; Huang Y; Ouyang Y; Zhu Y; Wang Y; Guo X; Yuan Y; Gong K
    Cancer Sci; 2018 Dec; 109(12):3714-3725. PubMed ID: 30238562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
    Cui S; Yang X; Zhang L; Zhao Y; Yan W
    Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
    Luo JF; Xu J; Zheng JZ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway.
    Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L
    Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FAM181A-AS1 promotes gliomagenesis by sponging miR-129-5p and upregulating ZRANB2.
    Jiang X; Chen D
    Aging (Albany NY); 2020 Oct; 12(20):20069-20084. PubMed ID: 33080570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
    Jiang K; Zhi XH; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
    Miao S; Wang J; Xuan L; Liu X
    Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
    Guo F; Fu Q; Wang Y; Sui G
    J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
    Zhou B; Guo H; Tang J
    Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
    Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
    Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
    Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
    Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA Solute Carrier Family 25 Member 21 Antisense RNA 1 Inhibits Cell Malignant Behaviors and Enhances Radiosensitivity of Gastric Cancer Cells by Upregulating Synuclein Gamma Expression.
    Wang L; Wang Z; Wang L
    Tohoku J Exp Med; 2022 Jun; 257(3):225-239. PubMed ID: 35444105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB.
    Hu Z; Chen Z; Jiang W; Fang D; Peng P; Yao S; Luo M; Wang L; Sun Z; Wang W; Wang X; Mao H; Ai F; Zhou P
    Biochem Genet; 2023 Dec; 61(6):2672-2690. PubMed ID: 37222961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
    Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.